Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Pedersen, Kjetil Boye ^a   Andersen, Kristin ^a   Fodstad, Øystein ^a   Mælandsmo, Gunhild Mari ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CALCIUM BINDING PROTEIN; CALVASCULIN; CASPASE 3; CASPASE 9; DNA FRAGMENT; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN S 100; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; RIBOZYME; UNCLASSIFIED DRUG; CASPASE; CATHEPSIN B; S100A4 PROTEIN, MOUSE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; NERVE FIBER GROWTH; OSTEOSARCOMA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; SENSITIZATION; WESTERN BLOTTING; CELL SURVIVAL; DRUG EFFECT; METABOLISM; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; CASPASES; CATHEPSIN B; CELL SURVIVAL; ENZYME ACTIVATION; HUMANS; INTERFERON-GAMMA; NF-KAPPA B; OSTEOSARCOMA; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; S100 PROTEINS; TUMOR CELLS, CULTURED;

EID: 13144273084     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-52     Document Type: Article

References (46)

1. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33(7): 37-668.
2. Davies BR, Barraclough R, Davies MP, Rudland PS: Production of the metastatic phenotype by DNA transfection in a rat mammary model. Cell Biol Int 1993, 17(9):871-879.
3. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Florenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O: Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996, 56(23):5490-5498.
4. Takenaga K, Nakamura Y, Sakiyama S: Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997, 14(3):331-337.
5. Kriajevska MV, Cardenas MN, Grigorian MS, Ambartsumian NS, Georgiev GP, Lukanidin EM: Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J Biol Chem 1994, 269(31):19679-19682.
6. Watanabe Y, Usada N, Minami H, Morita T, Tsugane S, Ishikawa R, Kohama K, Tomida Y, Hidaka H: Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett 1993, 324(1):51-55.
7. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K, Endo H: Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 1994, 124(5): 57-768.
8. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM: S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999, 59(18):4702-4708.
9. Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, Georgiev G, Berezin V, Bock E, Rygaard J, Cao R, Cao Y, Lukanidin E: The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 2001, 20(34 : 685-4695.
10. Belot N, Pochet R, Heizmann CW, Kiss R, Decaestecker C: Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta 2002, 1600(1-2):74-83.
11. Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E, Lukanidin E: Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 2000, 275(52):41278-41286.
12. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjornland K, Fodstad O, Maelandsmo GM: Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Pathol 2003, 200(5 : 89-595.
13. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G, Lukanidin E: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001, 276(25): 22699-22708.
14. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997, 15:749-795.
15. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
16. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997, 326(Pt 1):1-16.
17. Leist M, Jaattela M: Triggering of apoptosis by cathepsins. Cell Death Differ 2001, 8(4):324-326.
18. Cande C, Cecconi F, Dessen P, Kroemer G: Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 2002, 115(Pt 24): 727-4734.
19. Mathiasen IS, Jaattela M: Triggering caspase-independent cell death to combat cancer. Trends Mol Med 2002, 8(5): 12-220.
20. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. Embo J 1996, 15(15):3861-3870.
21. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997, 17(9): 5328-5337.
22. Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH: IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 2001, 93(2):262-268.
23. Dai C, Krantz SB: Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 1999, 93(10): 3309-3316.
24. Andersen K, Smith-Sorensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad O, Maelandsmo GM: Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest. Br J Cancer 2003, 88(12):1995-2001.
25. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R: In vivo imaging of NF-kappa B activity. J Immunol 2002, 168(3): 441-1446.
26. Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad O, Paus E: Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum. Tumour Biol 2004, 25(1-2):31-40.
27. Anderson Y, Juell S, Fodstad O: Down regulation of the antiapoptotic Mcl-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-EGFr-PE immunotoxin. Int J Cancer 2004 in press.
28. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jaattela M: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001, 153(5):999-1010.
29. Dussmann H, Kogel D, Rehm M, Prehn JH: Mitochondrial membrane permeabilization and superoxide production during apoptosis. A single-cell analysis. J Biol Chem 2003, 278(15): 2645-12649.
30. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R: Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 1999, 442(1):117-121.
31. Watanabe Y, Usuda N, Tsugane S, Kobayashi R, Hidaka H: Calvasculin, an encoded protein from mRNA termed pEL-98, 18A2, 42A, or p9Ka, is secreted by smooth muscle cells in culture and exhibits Ca(2+)- dependent binding to 36-kDa microfibril-associated glycoprotein. J Biol Chem 1992, 267(24):17136-17140.
32. Duarte WR, Iimura T, Takenaga K, Ohya K, Ishikawa I, Kasugai S: Extracellular role of S100A4 calcium-binding protein in the periodontal ligament. Biochem Biophys Res Commun 1999, 255(2):416-420.
33. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H: Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000, 275(51): 0096-40105.
34. Yui S, Nakatani Y, Mikami M: Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003, 26(6): 53-760.
35. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97(7): 889-901.
36. Sorci G, Riuzzi F, Agneletti AL, Marchetti C, Donato R: S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 2003, 23(14): 870-4881.
37. Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H, Lee MS: Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 2001, 276(16):13153-13159.
38. Li JH, Kluger MS, Madge LA, Zheng L, Bothwell AL, Pober JS: Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 2002, 161(4):1485-1495.
39. Chen MC, Hsu TL, Luh TY, Hsieh SL: Overexpression of bcl-2 enhances LIGHT- and interferon-gamma-mediated apoptosis in Hep3BT2 cells. J Biol Chem 2000, 275(49):38794-38801.
40. Hovig E, Andreassen A, Fangan BM, Borresen AL: A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomas. Cancer Genet Cytogenet 1992, 64(2):178-182.
41. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, Taniguchi T: Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000, 288(5475):2357-2360.
42. Hu X, Herrero C, Li WP, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, Haines GK, Ivashkiv LB: Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 2002, 3(9):859-866.
43. Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18(49 : 910-6924.
44. McConkey DJ: Calcium-dependent, interleukin 1-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei. J Biol Chem 1996, 271(37):22398-22406.
45. Robertson JD, Orrenius S, Zhivotovsky B: Review: nuclear events in apoptosis. J Struct Biol 2000, 129(2-3): 346-358.
46. Mikami M, Yamazaki M, Yui S: Kinetical analysis of tumor cell death-inducing mechanism by polymorphonuclear leukocyte-derived calprotectin: involvement of protein synthesis and generation of reactive oxygen species in target cells. Microbiol Immunol 1998, 42(3):211-221.